Website Changes
07/03/2010
MagForce Nanotechnologies AG receives European regulatory approval for its Nano Cancer® therapy for treatment of Brain Tumors
06/29/2010
NEW THERAPEUTIC RIDING PROGRAM IN LENOX MASSACHUSETTS
06/29/2010
A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro.
06/27/2010
The remarkable story of Virtualtrials.com
06/24/2010
Radiation Errors Reported in Missouri
06/23/2010
IsoRay and Hologic Sign Exclusive Worldwide License for Crucial Brain Cancer Treatment Device
FDA-Cleared GliaSite(R) Balloon Catheter Is World`s Only Device to Deliver Liquid Radiation Source Therapy
06/19/2010
Please vote for Musella Foundation! Help us win contest!
06/18/2010
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?
06/16/2010
Is Northwest Biotherapeutics (OTC:NWBO) Ready To Mount A Comeback?
06/11/2010
ImmunoCellular Drug Granted Orphan Drug Status
06/08/2010
NovoTTF-100A improved response, time to treatment failure in recurrent glioblastoma
06/08/2010
FDA approves first human neural stem cell clinical trial to treat brain tumors
06/08/2010
Brain cancer vaccine shows promise
06/08/2010
Fast track, "compassionate use," FDA approval bill for terminal patients filed.
06/08/2010
Exceptional Survival Data, Lower Costs Key to the Competitive Advantage of DCVax(R) - Northwest Biotherapeutics` Vaccine for Multiple Cancers
06/08/2010
BRAIN: 16% of patients with relapsed glioblastoma alive at 30 months (Avastin)
06/08/2010
Reradiating Recurrent Gliomas Is Effective, Well-Tolerated
06/07/2010
Initial Experience Involving Treatment and Retreatment With Carmustine Wafers in Combination With Oral Temozolomide: Long-term Survival in a Child With Re lapsed Glioblastoma Multiforme.
06/07/2010
Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy.
06/07/2010
Children`s Memorial Hospital, Chicago, First Children`s Hospital in Illinois to Acquire New Device for Pediatric Brain and Spine Tumor Removal
06/05/2010
Curis, Roche drug combats children`s brain tumors (Medulloblastoma)
06/05/2010
Interim Positive Results From Phase 2b Brain Cancer Study With Rindopepimut (PF-04948568 or CDX-110) Presented at 46th Annual ASCO Meeting
06/05/2010
Cilengitide Study Provides Long-Term Follow-up Data in Glioblastoma Patients Receiving Investigational Drug for More Than 4 Years
06/05/2010
The Mike Overall Golf Classic to be held June 21, 2010 - Beaumont, Texas
06/05/2010
SUCCESSFUL PHASE III CLINICAL TRIAL RESULTS REPORTED FOR NOVOCURE’S NOVEL MEDICAL DEVICE FOR TREATMENT OF RECURRENT GLIOBLASTOMA
which delivers brain tumor news and additions
to the website via RSS.